# Cellectar (CLRB) — News

CLRB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/clrb/news

## Recent headlines

- [Quebecor Inc.: National Bank of Canada cuts target price to C$71 from C$74](https://www.ainvest.com/news/quebecor-national-bank-canada-cuts-target-price-71-74-2610) — AInvest Wire, Oct 13, 2026
  National Bank of Canada has revised its target price for Quebecor Inc. (TSE:QBR.B) to C$71 from C$74, reflecting a slight downward adjustment in its valuation outlook for the company. The move suggests a recalibration of expectations, potentially influenced by recent market dynamics or internal…
- [StemPoint Capital LP reports 9.9% passive stake in Cellectar Biosciences Inc as of June 30 - SEC filing](https://www.ainvest.com/news/stempoint-capital-lp-reports-9-9-passive-stake-cellectar-biosciences-june-30-sec-filing-2608) — AInvest Wire, Aug 14, 2026
- Cellectar Biosciences files for $300M mixed securities shelf — AInvest Wire, May 24, 2024
  Cellectar Biosciences files for $300M mixed securities shelf Cellectar Biosciences, a late-stage clinical biopharmaceutical company, has recently filed a prospectus for a $300 million mixed securities shelf, highlighting its commitment to the discovery, development, and commercialization of…
- **Important** — Cellectar BioSciences surges 52% premarket after announcing Positive topline data achieving primary endpoint in pivotal clinical study of Iopofosine I 131 in Waldenstrom’s macroglobulinemia — AInvest Wire, Jan 8, 2024
  Cellectar BioSciences surges 52% premarket after announcing Positive topline data achieving primary endpoint in pivotal clinical study of Iopofosine I 131 in Waldenstrom’s macroglobulinemia Cellectar BioSciences, a late-stage clinical biopharmaceutical company, has announced positive topline data…
- **Important** — Cellectar Biosciences Shares Rise 10% After Being Granted Four Patents — AInvest Wire, Oct 2, 2023

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).